Rachel Sachs Explains the FTC's Pharmacy Benefit Manager Lawsuit & PBM Reform

Looking to drive meaningful change in the health care ecosystem? Look to the Deloitte Health Equity Institute. Health Affairs' Jeff Byers is joined by Deputy Editor Chris Fleming and Rachel Sachs of Washington University, St. Louis to discuss a recent lawsuit filed by the Federal Trade Commission (FTC) against the three largest pharmacy benefit managers (PBMs) in the country for rebating practices that the FTC claims resulted in inflating the list price of insulin. Health Affairs just released an Election 2024 resource hub for research and studies associated with key issues in the upcoming US presidential election. Related Articles:PBMs. What Are They Hiding? w/ Stacie Dusetzina (Health Affairs This Week)FTC sues major pharmacy benefit managers over insulin prices (Healthcare Dive)The Implications Of Rutledge v. PCMA For State Health Care Cost Regulation (Health Affairs Forefront)